touchIMMUNOLOGY joins Professor Emma Clark (University of Bristol, UK) at WCO21 to discuss the current limitations of osteoporosis diagnosis and the latest novel technologies for skeletal assessment.
1. Why is the diagnosis of osteoporosis so challenging? (00:16-02:13)
2. What are the strengths and limitations of currently available tools and services to diagnose osteoporosis? (02:13-04:28)
3. What are the most exciting novel technologies for skeletal assessment? (04:28-05:57)
4. What are the major barriers for implementation of novel technologies and how might these be overcome? (05:57-10:18)
Disclosures: Emma Clark is Vice Chair of the Novel Technologies working group, part of the Royal Osteoporosis Bone Research Academy.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.
Filmed in coverage of the WCO21 Annual Meeting.
Share this Video
Related Videos In Rheumatic Diseases
Atul Deodhar, ACR 2021: Bimekizumab Long-term HRQoL data in Ankylosing Spondylitis
Prof. Atul Deodhar (Oregon Health & Science University, Portland, OR, USA) kindly took the time to discuss the 3-yr interim health-related quality of life (HRQoL) data from the phase 2b BE AGILE study (NCT02963506) and its open-label extension (NCT03355573) investigating bimekizumab in ankylosing spondylitis. This information is brought to you by Touch Medical Media and […]
Tonia Vincent, ACR 2021: Advances in Osteoarthritis Therapy
In this interview, we talk with Professor Tonia Vincent (Centre for Osteoarthritis Pathogenesis, University of Oxford, Oxford, UK) around how the therapeutic landscape in OA is changing. This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology. The presentation entitled ‘OA: […]
Tonia Vincent, ACR 2021: Updates in Therapeutics for Osteoarthritis
TouchIMMUNOLOGY were delighted to talk with Professor Tonia Vincent (Centre for Osteoarthritis Pathogenesis, University of Oxford, Oxford, UK) around her presentation titled ‘OA: New Horizons for Therapy‘, which was presented at the ACR Convergence, 3-9 November 2021. This information is brought to you by Touch Medical Media and is not sponsored by, nor a part […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!